Management of X-linked adrenoleukodystrophy in Morocco: actual situation Article Swipe
F. Benjelloun
,
Yamna Kriouile
,
David Cheillan
,
H. Daoud-Tetouani
,
Layachi Chabraoui
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1186/s13104-017-2902-4
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1186/s13104-017-2902-4
We developed three protocols of X-linked Adrenoleukodystrophy management: general protocol, asymptomatic protocol, and heterozygous protocol. Over a period of 5 years, we recruited eight families with 16 patients. Clinically, the presentation is primary adrenal insufficiency and behavioral changes. All patients had elevated levels of very long fatty acids. This is the first study of X-linked adrenoleukodystrophy in Morocco. It shows the importance of this metabolic disease and broadens perspectives in terms of its diagnosis and its treatment.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s13104-017-2902-4
- https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-017-2902-4
- OA Status
- gold
- Cited By
- 3
- References
- 23
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2767271358
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2767271358Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s13104-017-2902-4Digital Object Identifier
- Title
-
Management of X-linked adrenoleukodystrophy in Morocco: actual situationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-11-07Full publication date if available
- Authors
-
F. Benjelloun, Yamna Kriouile, David Cheillan, H. Daoud-Tetouani, Layachi ChabraouiList of authors in order
- Landing page
-
https://doi.org/10.1186/s13104-017-2902-4Publisher landing page
- PDF URL
-
https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-017-2902-4Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-017-2902-4Direct OA link when available
- Concepts
-
Adrenoleukodystrophy, Asymptomatic, Adrenal insufficiency, Presentation (obstetrics), Medicine, Pediatrics, Disease, Leukodystrophy, Internal medicine, Surgery, Peroxisome, ReceptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2022: 1, 2020: 1, 2019: 1Per-year citation counts (last 5 years)
- References (count)
-
23Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2767271358 |
|---|---|
| doi | https://doi.org/10.1186/s13104-017-2902-4 |
| ids.doi | https://doi.org/10.1186/s13104-017-2902-4 |
| ids.mag | 2767271358 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/29116030 |
| ids.openalex | https://openalex.org/W2767271358 |
| fwci | 0.26722942 |
| mesh[0].qualifier_ui | Q000175 |
| mesh[0].descriptor_ui | D000326 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | diagnosis |
| mesh[0].descriptor_name | Adrenoleukodystrophy |
| mesh[1].qualifier_ui | Q000453 |
| mesh[1].descriptor_ui | D000326 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | epidemiology |
| mesh[1].descriptor_name | Adrenoleukodystrophy |
| mesh[2].qualifier_ui | Q000628 |
| mesh[2].descriptor_ui | D000326 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | therapy |
| mesh[2].descriptor_name | Adrenoleukodystrophy |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000328 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Adult |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D002648 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Child |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D002675 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Child, Preschool |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D002985 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Clinical Protocols |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006801 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Humans |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008297 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Male |
| mesh[10].qualifier_ui | Q000453 |
| mesh[10].descriptor_ui | D009018 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | epidemiology |
| mesh[10].descriptor_name | Morocco |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D016730 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Program Development |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D035583 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Rare Diseases |
| mesh[13].qualifier_ui | Q000175 |
| mesh[13].descriptor_ui | D000326 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | diagnosis |
| mesh[13].descriptor_name | Adrenoleukodystrophy |
| mesh[14].qualifier_ui | Q000453 |
| mesh[14].descriptor_ui | D000326 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | epidemiology |
| mesh[14].descriptor_name | Adrenoleukodystrophy |
| mesh[15].qualifier_ui | Q000628 |
| mesh[15].descriptor_ui | D000326 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | therapy |
| mesh[15].descriptor_name | Adrenoleukodystrophy |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D000328 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Adult |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D002648 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Child |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D002675 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Child, Preschool |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D002985 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Clinical Protocols |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D005260 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Female |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008297 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Male |
| mesh[23].qualifier_ui | Q000453 |
| mesh[23].descriptor_ui | D009018 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | epidemiology |
| mesh[23].descriptor_name | Morocco |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D016730 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Program Development |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D035583 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Rare Diseases |
| type | article |
| title | Management of X-linked adrenoleukodystrophy in Morocco: actual situation |
| biblio.issue | 1 |
| biblio.volume | 10 |
| biblio.last_page | 567 |
| biblio.first_page | 567 |
| topics[0].id | https://openalex.org/T11072 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Peroxisome Proliferator-Activated Receptors |
| topics[1].id | https://openalex.org/T11027 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9980999827384949 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1308 |
| topics[1].subfield.display_name | Clinical Biochemistry |
| topics[1].display_name | Metabolism and Genetic Disorders |
| topics[2].id | https://openalex.org/T12910 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9973999857902527 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1303 |
| topics[2].subfield.display_name | Biochemistry |
| topics[2].display_name | Eicosanoids and Hypertension Pharmacology |
| is_xpac | False |
| apc_list.value | 1110 |
| apc_list.currency | GBP |
| apc_list.value_usd | 1361 |
| apc_paid.value | 1110 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 1361 |
| concepts[0].id | https://openalex.org/C2777150068 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9932255148887634 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q366964 |
| concepts[0].display_name | Adrenoleukodystrophy |
| concepts[1].id | https://openalex.org/C2777910003 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7887238264083862 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1707292 |
| concepts[1].display_name | Asymptomatic |
| concepts[2].id | https://openalex.org/C2778129406 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6820982694625854 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2507454 |
| concepts[2].display_name | Adrenal insufficiency |
| concepts[3].id | https://openalex.org/C2777601897 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6240606307983398 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3409113 |
| concepts[3].display_name | Presentation (obstetrics) |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5974884033203125 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C187212893 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5763105154037476 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[5].display_name | Pediatrics |
| concepts[6].id | https://openalex.org/C2779134260 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5652809143066406 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[6].display_name | Disease |
| concepts[7].id | https://openalex.org/C2776100374 |
| concepts[7].level | 3 |
| concepts[7].score | 0.43540048599243164 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1821559 |
| concepts[7].display_name | Leukodystrophy |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.2905639410018921 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C141071460 |
| concepts[9].level | 1 |
| concepts[9].score | 0.15400126576423645 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[9].display_name | Surgery |
| concepts[10].id | https://openalex.org/C127078168 |
| concepts[10].level | 3 |
| concepts[10].score | 0.12718254327774048 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q138639 |
| concepts[10].display_name | Peroxisome |
| concepts[11].id | https://openalex.org/C170493617 |
| concepts[11].level | 2 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[11].display_name | Receptor |
| keywords[0].id | https://openalex.org/keywords/adrenoleukodystrophy |
| keywords[0].score | 0.9932255148887634 |
| keywords[0].display_name | Adrenoleukodystrophy |
| keywords[1].id | https://openalex.org/keywords/asymptomatic |
| keywords[1].score | 0.7887238264083862 |
| keywords[1].display_name | Asymptomatic |
| keywords[2].id | https://openalex.org/keywords/adrenal-insufficiency |
| keywords[2].score | 0.6820982694625854 |
| keywords[2].display_name | Adrenal insufficiency |
| keywords[3].id | https://openalex.org/keywords/presentation |
| keywords[3].score | 0.6240606307983398 |
| keywords[3].display_name | Presentation (obstetrics) |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.5974884033203125 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/pediatrics |
| keywords[5].score | 0.5763105154037476 |
| keywords[5].display_name | Pediatrics |
| keywords[6].id | https://openalex.org/keywords/disease |
| keywords[6].score | 0.5652809143066406 |
| keywords[6].display_name | Disease |
| keywords[7].id | https://openalex.org/keywords/leukodystrophy |
| keywords[7].score | 0.43540048599243164 |
| keywords[7].display_name | Leukodystrophy |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.2905639410018921 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/surgery |
| keywords[9].score | 0.15400126576423645 |
| keywords[9].display_name | Surgery |
| keywords[10].id | https://openalex.org/keywords/peroxisome |
| keywords[10].score | 0.12718254327774048 |
| keywords[10].display_name | Peroxisome |
| language | en |
| locations[0].id | doi:10.1186/s13104-017-2902-4 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S100014455 |
| locations[0].source.issn | 1756-0500 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1756-0500 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | BMC Research Notes |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-017-2902-4 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | BMC Research Notes |
| locations[0].landing_page_url | https://doi.org/10.1186/s13104-017-2902-4 |
| locations[1].id | pmid:29116030 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | BMC research notes |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/29116030 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:5678772 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://doi.org/10.1186/s13104-017-2902-4 |
| locations[3].id | pmh:oai:europepmc.org:4602784 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5678772 |
| locations[4].id | pmh:oai:doaj.org/article:28c37cc4abdd4b53a92238c427d472f7 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306401280 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[4].source.host_organization | |
| locations[4].source.host_organization_name | |
| locations[4].source.host_organization_lineage | |
| locations[4].license | cc-by-sa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | BMC Research Notes, Vol 10, Iss 1, Pp 1-6 (2017) |
| locations[4].landing_page_url | https://doaj.org/article/28c37cc4abdd4b53a92238c427d472f7 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5051353703 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3934-9261 |
| authorships[0].author.display_name | F. Benjelloun |
| authorships[0].countries | MA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I126477371 |
| authorships[0].affiliations[0].raw_affiliation_string | Biochemistry Laboratory, Faculty of Medicine and Pharmacy, University Mohammed V Souissi, Rabat, Morocco |
| authorships[0].institutions[0].id | https://openalex.org/I126477371 |
| authorships[0].institutions[0].ror | https://ror.org/00r8w8f84 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I126477371 |
| authorships[0].institutions[0].country_code | MA |
| authorships[0].institutions[0].display_name | Mohammed V University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | F. Z. Madani Benjelloun |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Biochemistry Laboratory, Faculty of Medicine and Pharmacy, University Mohammed V Souissi, Rabat, Morocco |
| authorships[1].author.id | https://openalex.org/A5001625751 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Yamna Kriouile |
| authorships[1].affiliations[0].raw_affiliation_string | Neuropediatric Department, Children’s Hospital, Rabat, Morocco |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Y. Kriouile |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Neuropediatric Department, Children’s Hospital, Rabat, Morocco |
| authorships[2].author.id | https://openalex.org/A5022204488 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9535-2567 |
| authorships[2].author.display_name | David Cheillan |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Inherited and Metabolic Diseases and Neonatal Screening, Hospices Civils , Lyon, France |
| authorships[2].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[2].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | D. Cheillan |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Inherited and Metabolic Diseases and Neonatal Screening, Hospices Civils , Lyon, France |
| authorships[3].author.id | https://openalex.org/A5022439616 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | H. Daoud-Tetouani |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I111088046, https://openalex.org/I127763184 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Biomedical Engineering, Bunker Hill Community College, Boston, USA |
| authorships[3].institutions[0].id | https://openalex.org/I111088046 |
| authorships[3].institutions[0].ror | https://ror.org/05qwgg493 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I111088046 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Boston University |
| authorships[3].institutions[1].id | https://openalex.org/I127763184 |
| authorships[3].institutions[1].ror | https://ror.org/05r3ht428 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I127763184 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | Bunker Hill Community College |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | H. Daoud-Tetouani |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Biomedical Engineering, Bunker Hill Community College, Boston, USA |
| authorships[4].author.id | https://openalex.org/A5084291474 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Layachi Chabraoui |
| authorships[4].countries | MA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210130352 |
| authorships[4].affiliations[0].raw_affiliation_string | Central Laboratory of Inherited and Metabolic Diseases, Ibn Sina Hospital, Rabat, Morocco |
| authorships[4].institutions[0].id | https://openalex.org/I4210130352 |
| authorships[4].institutions[0].ror | https://ror.org/038zpvz53 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210130352 |
| authorships[4].institutions[0].country_code | MA |
| authorships[4].institutions[0].display_name | Centre Hospitalier Ibn Sina |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | L. Chabraoui |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Central Laboratory of Inherited and Metabolic Diseases, Ibn Sina Hospital, Rabat, Morocco |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-017-2902-4 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Management of X-linked adrenoleukodystrophy in Morocco: actual situation |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11072 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Peroxisome Proliferator-Activated Receptors |
| related_works | https://openalex.org/W2087755698, https://openalex.org/W2147091288, https://openalex.org/W1966723305, https://openalex.org/W2079620348, https://openalex.org/W2945182189, https://openalex.org/W2416092981, https://openalex.org/W2047428686, https://openalex.org/W1986173688, https://openalex.org/W2050194209, https://openalex.org/W2319384010 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2022 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2020 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2019 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 5 |
| best_oa_location.id | doi:10.1186/s13104-017-2902-4 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S100014455 |
| best_oa_location.source.issn | 1756-0500 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1756-0500 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | BMC Research Notes |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-017-2902-4 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | BMC Research Notes |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s13104-017-2902-4 |
| primary_location.id | doi:10.1186/s13104-017-2902-4 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S100014455 |
| primary_location.source.issn | 1756-0500 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1756-0500 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | BMC Research Notes |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-017-2902-4 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | BMC Research Notes |
| primary_location.landing_page_url | https://doi.org/10.1186/s13104-017-2902-4 |
| publication_date | 2017-11-07 |
| publication_year | 2017 |
| referenced_works | https://openalex.org/W2037167329, https://openalex.org/W2148277974, https://openalex.org/W2095072855, https://openalex.org/W2020685866, https://openalex.org/W2471484986, https://openalex.org/W1264813249, https://openalex.org/W2151851024, https://openalex.org/W1972896422, https://openalex.org/W2319648345, https://openalex.org/W2054026377, https://openalex.org/W2438153122, https://openalex.org/W2141933546, https://openalex.org/W2130628979, https://openalex.org/W1968599579, https://openalex.org/W2032122670, https://openalex.org/W2590830249, https://openalex.org/W2043136531, https://openalex.org/W2026730238, https://openalex.org/W2145948329, https://openalex.org/W2031777625, https://openalex.org/W2041363411, https://openalex.org/W2179837613, https://openalex.org/W4253936898 |
| referenced_works_count | 23 |
| abstract_inverted_index.5 | 19 |
| abstract_inverted_index.a | 16 |
| abstract_inverted_index.16 | 26 |
| abstract_inverted_index.It | 58 |
| abstract_inverted_index.We | 0 |
| abstract_inverted_index.in | 56, 69 |
| abstract_inverted_index.is | 31, 49 |
| abstract_inverted_index.of | 4, 18, 43, 53, 62, 71 |
| abstract_inverted_index.we | 21 |
| abstract_inverted_index.All | 38 |
| abstract_inverted_index.and | 12, 35, 66, 74 |
| abstract_inverted_index.had | 40 |
| abstract_inverted_index.its | 72, 75 |
| abstract_inverted_index.the | 29, 50, 60 |
| abstract_inverted_index.Over | 15 |
| abstract_inverted_index.This | 48 |
| abstract_inverted_index.long | 45 |
| abstract_inverted_index.this | 63 |
| abstract_inverted_index.very | 44 |
| abstract_inverted_index.with | 25 |
| abstract_inverted_index.eight | 23 |
| abstract_inverted_index.fatty | 46 |
| abstract_inverted_index.first | 51 |
| abstract_inverted_index.shows | 59 |
| abstract_inverted_index.study | 52 |
| abstract_inverted_index.terms | 70 |
| abstract_inverted_index.three | 2 |
| abstract_inverted_index.acids. | 47 |
| abstract_inverted_index.levels | 42 |
| abstract_inverted_index.period | 17 |
| abstract_inverted_index.years, | 20 |
| abstract_inverted_index.adrenal | 33 |
| abstract_inverted_index.disease | 65 |
| abstract_inverted_index.general | 8 |
| abstract_inverted_index.primary | 32 |
| abstract_inverted_index.Morocco. | 57 |
| abstract_inverted_index.X-linked | 5, 54 |
| abstract_inverted_index.broadens | 67 |
| abstract_inverted_index.changes. | 37 |
| abstract_inverted_index.elevated | 41 |
| abstract_inverted_index.families | 24 |
| abstract_inverted_index.patients | 39 |
| abstract_inverted_index.developed | 1 |
| abstract_inverted_index.diagnosis | 73 |
| abstract_inverted_index.metabolic | 64 |
| abstract_inverted_index.patients. | 27 |
| abstract_inverted_index.protocol, | 9, 11 |
| abstract_inverted_index.protocol. | 14 |
| abstract_inverted_index.protocols | 3 |
| abstract_inverted_index.recruited | 22 |
| abstract_inverted_index.behavioral | 36 |
| abstract_inverted_index.importance | 61 |
| abstract_inverted_index.treatment. | 76 |
| abstract_inverted_index.Clinically, | 28 |
| abstract_inverted_index.management: | 7 |
| abstract_inverted_index.asymptomatic | 10 |
| abstract_inverted_index.heterozygous | 13 |
| abstract_inverted_index.perspectives | 68 |
| abstract_inverted_index.presentation | 30 |
| abstract_inverted_index.insufficiency | 34 |
| abstract_inverted_index.Adrenoleukodystrophy | 6 |
| abstract_inverted_index.adrenoleukodystrophy | 55 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7900000214576721 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.55205761 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |